Clinical Trial Update: Paclitaxel Micelles for Injection / Paclitaxel Injection in Combination With Cisplatin for First-line Therapy of Advanced NSCLC [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for paclitaxel micelles/injection with cisplatin as first-line therapy in advanced non-small cell lung cancer (NSCLC).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Paclitaxel Injection (paclitaxel)
• Paclitaxel Micelles for Injection (paclitaxel micelle formulation)

Snippet

Sponsor: Shanghai Yizhong Pharmaceutical Co., Ltd. | Conditions: Non-Small Cell Lung Cancer(NSCLC) | Phase 3 | Status: UNKNOWN